Herrera-Montalvo, Luis Alonso

Dr. Luis A. Herrera was born in the city of Orizaba, Veracruz. He holds a PhD in Biomedical Sciences from the National Autonomous University of Mexico (UNAM) and is a Biologist from the same university. He did a postdoctoral fellowship at the School of Medicine at Stanford University, USA. He has had research stays at the Institutes of Human Genetics and Toxicology and Pharmacology in Germany and the United States. From 2001 to date, he is a researcher at the Institute of Biomedical Research of the UNAM. In 2003 he joined the National Cancer Institute (INCan) as Deputy Director of Research where he consolidated research policies. Subsequently, he was Director of Research at INCan for 10 years, from where he managed the Hereditary Cancer Clinic, the Prevention Research Center, the Prevention Clinics in Torreón, Monterrey and Puebla. He founded and developed the Mexican College for Cancer Research. From June 2019 to February 2023 he was Director of the National Institute of Genomic Medicine of the Ministry of Health. Since January 2023 he was appointed National Dean of the School of Medicine and Health Sciences of ITESM. His research has focused on the area of carcinogenesis; mainly in the relationship between chromosomal instability and different tumors. He has published 173 original research papers, and more than 50 of scientific analysis and dissemination in journals of international and national circulation. He has been a professor in the Doctoral programs in Biomedical Sciences; Master's and Doctorate in Medical, Dental and Health Sciences, as well as in the Faculties of Sciences and Medicine of the UNAM. He has directed more than 40 undergraduate, specialty and graduate theses. Among the distinctions that have been awarded to him are: the National University Distinction for Young University Researchers in the area of Research in Natural Sciences, the "Alfonso Caso" Medal, the recognition as National Researcher Level III. He is a member of the Mexican Academy of Sciences, a Full Member of the National Academy of Medicine, a Member of the American Association for Cancer Research and the American Society of Clinical Oncology.